524804:BOM
Aurobindo Pharma
₹ 1.660,90
arrow_downward
-0,84%(-14,10) 1D
16 okt, 15:02:19 GMT+5:30 · INR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 524804 genereren…
Openen
₹ 1.683,55
Hoog
₹ 1.683,55
Laag
₹ 1.654,75
Beursw.
955,70Â mld.
Gem. vol.
29,66K
Volume
10,72K
Koers/winst-verhouding
25,95
52 wk hoog
₹ 1.739,95
52 wk laag
₹ 1.080,10
WPA
₹ 64,00
Uitstaande aandelen
585,90Â mln.
Aantal medewerkers
29K
Openen
₹ 1.683,55
Hoog
₹ 1.683,55
Laag
₹ 1.654,75
Beursw.
955,70Â mld.
Gem. vol.
29,66K
Volume
10,72K
Koers/winst-verhouding
25,95
52 wk hoog
₹ 1.739,95
52 wk laag
₹ 1.080,10
WPA
₹ 64,00
Uitstaande aandelen
585,90Â mln.
Aantal medewerkers
29K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Moneycontrol.com
·
2 dagen geleden
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
Profiel
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
Over Aurobindo Pharma
CEO-
Medewerkers29,2K
Opgericht1986
HoofdkantoorHaiderabad, Andhra Pradesh, India
Sector-
Websiteaurobindo.com